Relamorelin

DRUG6 trials

Sponsors

Allergan, Motus Therapeutics, Inc.

Conditions

Diabetes MellitusDiabetes Mellitus ComplicationsGastric MotilityGastroparesis

Phase 1

Effect of Relamorelin on Satiation, Gastric Volume, Gastric Accommodation and Distal Gastric Function in Healthy Volunteers

CompletedNCT02466711

Motus Therapeutics, Inc.Gastric Motility

Start: 2015-06-30End: 2015-09-30Updated: 2016-09-22

Phase 2

Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis

CompletedNCT02357420

AllerganDiabetes Mellitus, Diabetes Mellitus Complications, Gastroparesis

Start: 2015-01-29End: 2016-06-09Updated: 2019-07-24

Phase 3

A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis 01

TerminatedNCT03285308

AllerganDiabetes Mellitus, Gastroparesis

Start: 2017-09-29End: 2020-07-08Updated: 2021-07-29

A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04

TerminatedNCT03383146

AllerganDiabetes Mellitus, Gastroparesis

Start: 2018-02-01End: 2020-11-05Updated: 2021-11-23

A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03

TerminatedNCT03420781

AllerganDiabetes Mellitus, Gastroparesis

Start: 2018-01-24End: 2020-10-30Updated: 2021-12-22

Study to Evaluate the Safety and Efficacy of Relamorelin in Participants With Diabetic Gastroparesis Study 02

TerminatedNCT03426345

AllerganDiabetes Mellitus, Gastroparesis

Start: 2018-02-16End: 2020-07-16Updated: 2021-08-06

Related Papers

Overall safety of relamorelin in adults with diabetic gastroparesis: Analysis of phase 2a and 2b trial data

Alimentary Pharmacology & Therapeutics2020-04-1737 citations

A179 CANADIAN INVOLVEMENT IN THE EVALUATION OF NOVEL THERAPY FOR DIABETIC GASTROPARESIS: OVERVIEW OF PLEDGE TRIALS

Journal of the Canadian Association of Gastroenterology2020-02-01

Overall Safety and Tolerability of Relamorelin in Adults With Diabetic Gastroparesis: Analysis of Phase 2a and Phase 2b Trial Data

The American Journal of Gastroenterology2018-10-012 citations

Efficacy and Safety of Relamorelin in Diabetics With Symptoms of Gastroparesis: A Randomized, Placebo-Controlled Study.

2017-07-29109 citations

Effects of ghrelin receptor agonist, relamorelin, on gastric motor functions and satiation in healthy volunteers

Neurogastroenterology & Motility2016-06-0955 citations